US Stock MarketDetailed Quotes

ATRA Atara Biotherapeutics

Watchlist
  • 11.400
  • +1.470+14.80%
Close Dec 20 16:00 ET
  • 11.550
  • +0.150+1.32%
Post 20:01 ET
65.66MMarket Cap-0.45P/E (TTM)

Atara Biotherapeutics Key Stats

Atara Biotherapeutics Q3 2024 Earnings Date

Currency:USDNov 12, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
35.17M
40.19M
+5.02M
Beat Est.
+1544.90%
+1779.79%
+14.28%
EPS
-20.09
-2.93
+17.16
Beat Est.
-21.77%
+82.13%
+85.42%
Buy

Dec 21, 2024

Atara Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 37.350M--
--2024/Q4-- / 33.095M--
Nov 12, 20242024/Q340.190M / 35.168M--
--2024/Q228.640M / 37.092M--
--2024/Q127.357M / 24.690M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 37.350M--
--2024/Q4-- / 33.095M--
Nov 12, 20242024/Q340.190M / 35.168M--
--2024/Q228.640M / 37.092M--
--2024/Q127.357M / 24.690M--

Unlock Free Earnings Estimates

Atara Biotherapeutics Earnings Reports

Read more

Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Analysis

Analyst Rating

Updated: Dec 21, 2024

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data